Every 5 years, the FDA has to renegotiate billions of dollars in user fees with the drug and medical device companies it regulates. This is one of those years, and Congress has to pass the latest user fee agreements by the end of September to keep FDA running. We break down this controversial process and what other health policies could pass in its wake.

Guest:

Sarah Karlin-Smith, Senior Writer, Pink Sheet

Read a full transcript and dig deeper into the issues explored in today's episode on our website.

Support this type of journalism today by making a donation.

Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff.

Follow us on Twitter.

Hosted on Acast. See acast.com/privacy for more information.